WOW ! is all I can say . I've followed this stock for many years...

First 34 Last

Share
Profile

Follow
bungalowbill

3,227 Posts.

648

11/05/17

11:18

Post #: 24620616
Share

Originally posted by madamswer ↑

@hottuna,

You are to be commended for your nuggety ferreting around and looking for dangerous flaws in business models, and for then alerting people to them.

To the extent that there is excessive spruiking and over-promoting of stocks without any well-founded countervailing arguments supported by fact-based research, you are providing a valuable public service for free.

The part of your post that sticks in my craw is that the stockbroker tells its clients to buy the share with a Target Price of $3.38 (accurate to 2 decimal places, no less, connoting some sort of analytical precision, presumably).

But when the broker's advice is proven to be inordinately inept, it then blames to company for it, citing "apparent lack of transparency" as the reason why the broking analyst got it so ludicrously wrong.

Surely the analysis that resulted in the target price that was generated should have factored in the "lack of transparency"?

And then, after this unbridled professional incompetence, the broker simply washes his hands of the entire sorry saga, dismissively brushes it all under the carpet and moves onto generate more "Target Prices" on the next big thing which gets peddled to poor, unwitting investors.

It's a heinous profession.

Imagine if a doctor made such bad mistakes in their diagnosis of a health condition, or a lawyer dispensed such bad legal advice.

And then, when the adverse consequences of their malpractice were brought to their respective attention, they simply said, "Well, hard luck. I'm simply not dealing with that situation any longer; I'm moving onto the next patient/case."

Like I said, stockbroking is a contemptible profession.

Expand

WOW ! is all I can say . I've followed this stock for many years & have relatives who have grown sandalwood trees on their farm in the west . That is one serious short & the ASX / ASIC needs to look at that big time. I would humbly suggest that anyone looking money here , contact the ASX to request an inquiry. I nearly bought at 60 cents yesterday - this is trading like it might be taken all the way.

QIN Price at posting: 40.0¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 50 more messages in this thread...

First 34 Last

Add QIN (ASX) to my watchlist

WOW ! is all I can say . I've followed this stock for many years...

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News